Traders should monitor the upcoming Information Statement/Prospectus for material details on the merger terms, dilution, and valuation. The positive portfolio performance update may support investor sentiment, but the lack of deal economics (size, structure, share exchange ratio) limits immediate pricing impact. Watch for shareholder vote timing and SEC effectiveness announcement.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 16 $7.68entry
- T+1 · 7mo ago −0.78%α −1.99% · $7.62
- T+5 · 7mo ago −7.81%α −8.78% · $7.08
- T+20 · 6mo ago +7.81%α +1.18% · $8.28
- T+60 · 4mo ago −64.32%α −71.37% · $2.74
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
SRx Health Solutions (SRXH) filed a Form S-4 with the SEC regarding its proposed merger with EMJ Crypto Technologies (EMJX), providing an update on portfolio performance showing a 3.5% gain in its hedging pool and 8% gain in long treasury holdings. The company emphasized progress on the merger and plans to report performance metrics quarterly going forward.
Key Facts
- SRXH filed a Form S-4 with the SEC related to its merger with EMJ Crypto Technologies (EMJX).
- The company reported an approximate 3.5% gain in its hedging pool and 8% gain in long treasury investment holdings as of mid-April 2026.
- Performance attributed to EMJX’s algorithm ahead of the merger.
- The definitive Information Statement/Prospectus will be sent to shareholders after SEC declaration.
- Forward-looking statements emphasize risks including shareholder approval, regulatory conditions, and market factors.
Financial Impact
Merger pending; no direct financial impact quantified yet. Portfolio gains reported as percentages only (3.5% hedging pool, 8% treasury holdings), no dollar values disclosed.
Risk Factors
- Merger not yet approved, subject to shareholder and regulatory clearance.
- No financial terms disclosed (deal value, exchange ratio, dilution), creating uncertainty.
- Forward-looking statements highlight material risks including market conditions and transaction completion risk.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3275333 |
Track record
30 reports on SRXH
4 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +77.11% at T+60 after the Jun 18, 2026 report. 4 of 6 went positive at some point.
Filters
- Nov 20, 20261d ago Press Release Neutral 3/10 Entry $0.8402 Now $0.8000 −4.78% settles Nov 30
- Nov 20, 20261d ago SC 13D Neutral 5/10 Entry $0.9950 Now $0.8000 −19.60% settles Nov 30
- Oct 30, 202622d ago Press Release Neutral 3/10 Entry $1.01 to $0.8116 Now $0.8000 −20.79% ▼ −19.64% −16.94% vs SPY
- Oct 7, 20266w ago 8-K Mixed 6/10 Entry $1.49 to $1.29 Now $0.8000 −46.31% ▼ −13.42% −12.44% vs SPY
- Oct 6, 20266w ago 8-K Neutral 4/10 Entry $1.49 to $1.29 Now $0.8000 −46.31% ▼ −13.42% −12.44% vs SPY
- Sep 24, 20268w ago Press Release Neutral 3/10 Entry $1.73 to $1.61 Now $0.8000 −53.76% ▼ −6.94% −6.52% vs SPY
- Sep 9, 202610w ago 8-K Neutral 3/10 Entry $1.51 to $1.60 Now $0.8000 −47.02% ▲ +5.96% +6.62% vs SPY
- Sep 2, 202611w ago 8-K Neutral 5/10 Entry $1.56 to $1.59 Now $0.8000 −48.72% ▲ +1.92% +3.07% vs SPY
- Aug 28, 202612w ago 8-K Bearish 5/10 Entry $1.68 to $1.59 Now $0.8000 +52.38% ▲ +5.65% +5.51% vs SPY
- Aug 19, 202613w ago 8-K Mixed 5/10 Entry $1.87 to $1.84 Now $0.8000 −57.22% ▼ −1.60% −1.22% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers